Drug intelligence / Profile preview

yttrium (90Y) resin microspheres

Development stage
Unknown
Lead developer
Sirtex
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intra-arterial
01

Overview

Yttrium (90Y) resin microspheres are a radiopharmaceutical used in Selective Internal Radiation Therapy (SIRT), also known as radioembolization. The product consists of biocompatible resin microspheres, approximately 20 to 60 micrometers in diameter, containing the beta-emitting isotope Yttrium-90. It is primarily indicated for the treatment of unresectable metastatic colorectal cancer (mCRC) in the liver and hepatocellular carcinoma (HCC). The microspheres are delivered via a catheter into the hepatic artery, where they become trapped in the microvasculature of the tumor. Once lodged, the Yttrium-90 isotope emits high-energy beta radiation with a mean range of 2.5 mm in tissue, delivering a localized, lethal dose of radiation to the tumor cells while minimizing exposure to healthy liver tissue. This dual mechanism of action involves both mechanical embolization of the tumor's blood supply and targeted internal radiotherapy.

Brand names
SIR-Spheres
Other names
yttrium-90 resin microspheresyttrium90 resin microspheresyttrium 90 resin microspheres90Y resin microspheresyttrium-90 microsphere injectionyttrium90 microsphere injectionyttrium 90 microsphere injectionY-90 resin microspheresY90 resin microspheresY 90 resin microspheres
02

Targets

DNA

Beyond the preview

Go deeper on yttrium (90Y) resin microspheres.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yttrium (90Y) resin microspheres.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call